The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure

Clinical Chemistry

Volumn 53, Issue 5, 2007, Pages 866-873

  Seferian, Karina R ^a   Tamm, Natalia N ^a   Semenov, Alexander G ^b   Mukharyamova, Kadriya S ^c   Tolstaya, Anastasya A ^c   Koshkina, Ekaterina V ^d   Kara, Andrei N ^b   Krasnoselsky, Mihail I ^e   Apple, Fred S ^f   Esakova, Tatiana V ^c   Filatov, Vladimir L ^a   Katrukha, Alexey G ^a  

^a HyTest Ltd   (Finland)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c Moscow Research Institute of Medical Ecology   (Russian Federation)

^d 67 City Hospital   (Russian Federation)

^e A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOREACTIVITY; MOLECULAR DYNAMICS;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, LIQUID; FLUOROIMMUNOASSAY; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 34248336125     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.076141     Document Type: Article

References (9)

1. Seidler T, Pemberton C, Yandle T, Espiner E, Nicholls G, Richards M. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 1999;255:495-501.
2. Shimizu H, Masuta K, Aono K, Asada H, Sasakura K, Tamaki M et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002;316:129-35.
3. Shimizu H, Masuta K, Asada H, Sugita K, Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2003;334:233-9.
4. Schellenberger U, O'Rear J, Guzzetta A, Jue RA, Protter AA, Pollitt NS. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 2006;451:160-6.
5. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7.
6. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lovgren T, Severina ME et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-85.
7. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AH, Tate J et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51:486-93.
8. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma; evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993;76:832-8.
9. Hawkridge AM, Heublein DM, Bergen HR 3rd, Cataliotti A, Burnett JC Jr, Muddiman DC. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 2005;102:17442-7.